Duey Marc, a director at Aprea Therapeutics, Inc. ($APRE), made one open market purchase of common shares worth about $25,000 in the last 365 days, with the most recent on December 10, 2025. This ranks him 3,614th among 4,983 insiders by purchase amount, below the average of $1.46 million across 3.29 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 10, 2025 | Aprea Therapeutics, Inc. | $APRE | Duey Marc | Director | P | Common Warrant | 21459 | $0.00 | 21,459.0000 | 6,372,938 | 9999.99% | 0.34% |
| Dec. 10, 2025 | Aprea Therapeutics, Inc. | $APRE | Duey Marc | Director | P | Common Stock | 21459 | $1.17 | 256,757.0000 | 6,372,938 | 9.12% | 0.34% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Duey Marc | Director | A | Common Stock | 1045 | $0.00 | 235,298.0000 | 5,993,866 | 0.45% | 0.02% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Duey Marc | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| Oct. 18, 2024 | Aprea Therapeutics, Inc. | $APRE | Duey Marc | Director | S | Common Stock | 6462 | $4.58 | 234,253.0000 | 5,939,755 | 2.68% | 0.11% |
| Oct. 16, 2024 | Aprea Therapeutics, Inc. | $APRE | Duey Marc | Director | P | Common Stock | 30000 | $4.39 | 240,715.0000 | 5,939,755 | 14.24% | 0.51% |
| Oct. 14, 2024 | Aprea Therapeutics, Inc. | $APRE | Duey Marc | Director | P | Common Stock | 190 | $2.58 | 210,715.0000 | 5,939,755 | 0.09% | 0.00% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | Duey Marc | Director | A | Common Stock | 1045 | $0.00 | 210,525.0000 | 4,198,326 | 0.50% | 0.02% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | Duey Marc | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |